Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins

J Med Chem. 2008 Feb 28;51(4):717-20. doi: 10.1021/jm701358v. Epub 2008 Feb 1.

Abstract

A series of acylpyrogallols were designed, synthesized, and evaluated as small-molecule inhibitors of antiapoptotic Bcl-2 proteins. The most potent compound 9 (TM-179) binds to Bcl-2 with an IC50 of 170 nM and to Mcl-1 with a Ki of 37 nM. Compound 9 potently inhibits cell growth and induces apoptosis in human breast and prostate cancer cell lines.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Apoptosis*
  • Benzothiazoles / chemical synthesis*
  • Benzothiazoles / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Models, Molecular
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors*
  • Pyrogallol / analogs & derivatives*
  • Pyrogallol / chemical synthesis*
  • Pyrogallol / pharmacology
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Benzothiazoles
  • Proto-Oncogene Proteins c-bcl-2
  • TM 179
  • Pyrogallol